Since this increased TGFβ signaling seems compatible with the survival of Tgfb3+/− mice, it is possible that adult Tgfb3+/− mice will develop progressive cardiovascular disease such as aortic aneurysm, valvular heart disease, and cardiomyopathy. This evidence concerns the gene TGFB3 and heart valve disorder.